Skip to main content
SpringerLink
Log in

Testosteronsubstitution in der Praxis

  • Chapter
Der alternde Mann

  • 30 Accesses

Zusammenfassung

Ziel der Testosteronbehandlung ist es, möglich physiologische Serumkonzentrationen zu erreichen. Das setzt voraus, dass Androgene eingesetzt werden, die stabil sind und nicht in der Leber metrabolisiert werden, da sonst nicht ausreichend biologish aktives, freies Testosteron zur Verfügung steht. Weiterhin ist der Wirkungsmechanismus von Testosteron und seiner Metaboliten zu beachten (Abb. 54).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Lunglmayr G: Trial on Androgen Supplementation in Aging Male. In: Waites, GMH, Frick J, Baker, GWH (Eds.): Current Advances in Andrology, Monduzzi Editore S.p.A., Bologna (1997) 289–292

    Google Scholar 

  2. Krause W: Testosteronsubstitution in der mannlichen Seneszenz. Beilage für Hautarzte, Springer Verlag Berlin, Heidelberg (2000)

    Google Scholar 

  3. Morales A, Heaton JP, Carson CC III: Andropause: a misnomer for a true clinical entity. J Urol (2000) 163:705–712

    Article  PubMed  CAS  Google Scholar 

  4. Morales A, Bain RJ, Ruijs A, Chapdelaine A, Tremblay RR: Clinical practice guidelines for screening and monitory mal patients receiving testosterone supplementation therapy. Int. J. Impot. Res. (1996) 8:95–99

    PubMed  CAS  Google Scholar 

  5. Christiansen K: Behavioural correlates of testosterone. In: Nieschlag E, Behre HM (Eds.): Testosterone. Action-Deficiency-Substitution, Springer Verlag Berlin, Heidelberg (1998)

    Google Scholar 

  6. Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C: Testosterone replacement in older hypogonadal men: a 12 month randomized controlled trial. J. Clin. Endocrinol. Metab. (1997) 82:1661–1667

    Article  PubMed  CAS  Google Scholar 

  7. Nieschlag E, Behre HM (Eds.): Testosterone. Action-Deficiency-Substitution. 2nd Edition, Springer, Verlag Berlin-Heidelberg (1998)

    Google Scholar 

  8. Jockenhovel F: Mannlicher Hypogonadismus Aktuelle Aspekte der Androgen substitution. Uni-Med. Verlag Bremen (1999)

    Google Scholar 

  9. Vermeulen A, Kaufman JM, Giagulli VA: Influence of some biological indices on sex hormone binding globulin and androgen levels in aging and obese males. J Clin Endocrinol Metab (1996) 81:1821–1827

    Article  PubMed  CAS  Google Scholar 

  10. Tenover JL: Male hormone replacement therapy including “andropause”. Endocrinol Metab Clin North Am (1998) 27:969–987

    Article  PubMed  CAS  Google Scholar 

  11. Hermann M, Berger P: Hormone replacement in the aging male? Exp Geontol (1999) 34:923–933

    Article  CAS  Google Scholar 

  12. Seidman SN, Walsh BT: Testosterone and depression in aging men. Am J Geriatr Psychiatry (1999) 7:18–33

    PubMed  CAS  Google Scholar 

  13. Nieschlag E, Behre HM: Therapie mit Testosteron. In: Nieschlag E, Behre HM (Hrsg.): Andrologie: Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer Verlag Berlin, Heidelberg (1996) 315–329

    Google Scholar 

  14. Behre HM, von Eckardstein S, Kliesch S, Nieschlag E: Long-term substitution therapy of hypogonadal men with trans scrotal testosterone over 7-10 years. Clin. Endocrinol. (1999) 50:629–635

    Article  CAS  Google Scholar 

  15. Jockenhovel et al: Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Metabolism (1999) 48:590–596

    Article  PubMed  CAS  Google Scholar 

  16. Snyder PJ et al: Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab (1999) 84:2647–2653

    Article  PubMed  CAS  Google Scholar 

  17. Alblin RJ: A retrospective and prospective overview of prostate-specific antigen. J Cancer Res Clin (1997) 24: 811–816

    Google Scholar 

  18. Bangma CH: Reihenuntersuchungen zur Entdeckung von Prostatakarzinomen. Urologe A (2000) 39:334–340

    Article  PubMed  CAS  Google Scholar 

  19. Catalona WJ, Richie JP, Ahmann FR, Hudson A, Scardino PR, Flanigan RC, de Kernion JB, Ratcliff TL, Kavoussi LR, Dalkin BL, Bedfors Waters W, McFarlane MT, Southwick P: Comparison of digital rectal examination and serum specific antigen in the early detection of a prostate cancer: Results of a multicenter clinical trial of 6630 men. J Urol (1994) 151:1283–1290

    PubMed  CAS  Google Scholar 

  20. Catalona WJ, Smith DS, Ratcliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N Engl J Med (1991) 324:1156–1159

    Article  PubMed  CAS  Google Scholar 

  21. De Angelis G, Brandt B, Schmidt HP, Sejonow A: Vom Antigen zum Tumormarker. Urologe A (2000) 39:309–312

    Article  PubMed  Google Scholar 

  22. Hinkelbein W, Miller K, Wiegel T (Hrsg.): Prostatakarzinom — urologische und strahlentherapeutische Aspekte. Springer, Berlin (1999)

    Google Scholar 

  23. Hoedemaeker RF, Boeken Kruger AE, Van den Kwast TH: How many biopsies should be taken for proper diagnosis and grading; in Kurth KH, Mickisch GH, Schrader FH (Eds.): Renal, bladder and prostate cancer; an update, Parthenon Publishing Group, London (1999)

    Google Scholar 

  24. Lein M, Stephan C, Jung K, Schnorr D, Loening SA: Molekulare Formen des prostataspezifischen Antigens und des humanen Kallikreins 2 als magliche Indikatoren in der Prostatakarzinomdiagnostik. Urologe A (2000) 39:313–323

    Article  PubMed  CAS  Google Scholar 

  25. Luboldt HJ, Altwein JE, Bichler KH, Czaja D, Htising J, Fornara P, Jackel KH, Ltibben G, Schalkhauser K, Weillbach L, Wirth M, Rtibben H: Frtiherkennung des Prostatakarzinoms — Erste Ergebnisse einer prospektiven multizentrischen Studie in Deutschland. Urologe A (1999) 38:114–123

    Article  PubMed  CAS  Google Scholar 

  26. Luboldt HJ, Htising J, Altwein JE, Bichler KH, Czaja D, Fornara P, Jackel KH, Schalkhauser K, Weißbach L, Wirth M, Rtibben H: Frtiherkennung des Prostatakarzinoms in der urologischen Praxis mit digitaler rektaler Untersuchung und prostataspezifischem Antigen. Urologe A (2000) 39:330–333

    Article  PubMed  CAS  Google Scholar 

  27. Moul JW: Prostata spezific antigen only preogression of prostate cancer. J Urol (2000) 163:1632–1642

    Article  PubMed  CAS  Google Scholar 

  28. Nakamura RM: Current status and future directions in standardization of prostatespecific-antigen immunoassay. Urology (1998) (Suppl. 5A) 51:83–87

    Article  PubMed  CAS  Google Scholar 

  29. Desterling JE, Suman VJ, Zincke H, Boswick DG: PSA-detected (clinical stage Tlc or BO) prostate cancer; pathologically significant tumors. Urol Clin North Am (1993) 20:687–693

    Google Scholar 

  30. PannekJ, Brands FH: Zusatzliche Hilfen bei der Erkennung von Prostatakarzinomen. Urologe A (2000) 39:324–329

    Article  Google Scholar 

  31. Rtibben H (Hrsg). Uroonkologie. Springer, Berlin (1999)

    Google Scholar 

  32. Schroeder FH, Kranse R, Rietbergen J, Hoedemaeker R, Kirkels W: The European Randomized Study of Screening for Prostate Cancer (ERSPC). Members of the ERSPC, Section Rotterdam. Eur Urol (1999) 35:539–543

    Article  Google Scholar 

  33. Sokoll LJ, Chan DW: Prostate-specific antigen. Its discivery and biochemical characteristics. Urol Clin North Am (1997) 24:253–259

    Article  PubMed  CAS  Google Scholar 

  34. Bartels H: Transrektale Prostatasonographie. Springer, Berlin (1996)

    Book  Google Scholar 

  35. Bertermann H: Ob BPH oder Krebs — im Ultraschall verrat die Prostata fast alles. Ap Urologie Nephrologie (1999) 3,4:24–26

    Google Scholar 

  36. Bertermann H: Transrektale Sonografie von Prostata und Samenblasen, Ecomed, Lansberg/Lech (1997)

    Google Scholar 

  37. Hinkelbein W, Miller K, Weigel T: Prostatakarzinom. Springer, Berlin (1999)

    Google Scholar 

  38. Jocham D, Miller K: Praxis der Urologie, Thieme, Stuttgart (1994)

    Google Scholar 

  39. Wieland W: Transrektaler Ultraschall, Verlag, Frankfurt/Main (1997)

    Google Scholar 

  40. Loch T: Weiterentwicklung des transrektalen Ultraschalls. Urologe A (2000) 39: 341–347

    Article  PubMed  CAS  Google Scholar 

  41. Lorenz A, Ermert H, Sommerfeld HI, Garcia-Schtirmann M, Senge T, Philippou S: Ultraschallelastographie der Prostata. Ultraschall in Med (2000) 21:8–15

    Article  CAS  Google Scholar 

  42. Krause W: Testosteronsubstitution in der mannlichen Seneszenz. Beilage für Hautarzte, Springer Verlag, Berlin, Heidelberg 2000

    Google Scholar 

  43. Morales A, Heaton J, Carson CC III: Andropause: a misnomer for a true clinical entity. J Urol (2000) 163:705–712

    Article  PubMed  CAS  Google Scholar 

  44. Morales AR, Bain J, Ruijs A, Chapdelaine A, Tremblay RR: Clinical practice guidelines for screening and monitory mal patients receiving testosterone supplementation therapy. Int. J. Impot. Res. (1996) 8:96–99

    Google Scholar 

  45. Nieschlag E, Behre HM (Eds.): Testosterone. Action-Deficiency-Substitution. 2nd Edition, Springer Verlag, Berlin, Heidelberg 1998

    Google Scholar 

  46. Jockenhovel F: Mannlicher Hypogonadismus Aktuelle Aspekte der Androgensubstitution. Uni-Med. Verlag Bremen 1999

    Google Scholar 

  47. Tenover JL: Male hormone replacement therapy including “andropause”. Endocrinol Metab Clin North Am (1998) 27:969–987

    Article  PubMed  CAS  Google Scholar 

  48. Hermann M, Berger P: Hormone replacement in the aging male? Exp Geontol (1999) 34:923–933

    Article  CAS  Google Scholar 

  49. Nieschlag E, Behre HM: Therapie mit Testosteron. In: Nieschlag E, Behre HM (Hrsg.): Andrologie: Grundlagen und Klinik der reproduktiven Gesundheit des Mannes. Springer Verlag, Berlin, Heidelberg (1996) 315–329

    Google Scholar 

  50. Behre HM, von Eckardstein S, Kliesch S, Nieschlag E: Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years. Clin. Endocrinol. 50 (1999) 629–635

    Article  CAS  Google Scholar 

  51. Jockenhovel et al: Influence of various modes of androgen substitution on serum lipids and lipoproteins in hypogonadal men. Metabolism. May (1999), (5) 48:590–596

    CAS  Google Scholar 

  52. Franke WW, Berendonk B: Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 1997; 43:1262–1279

    PubMed  CAS  Google Scholar 

  53. Richter A: Doping in der DDR — Nur die Medaillen zahlten. Deutsches Arzteblatt 2000; 97:CI519–1520

    Google Scholar 

  54. Schanzer W: Review — Metabolism of anabolic androgensteroids. Clin Chem (1996) 42:1001–1020

    PubMed  CAS  Google Scholar 

  55. Yesalis CE, Kennedy NJ, Kopstein AN, Bahrke MS: Anabolic-androgenic steroid use in the United States. Jama (1993) 270:1217–1221

    Article  PubMed  CAS  Google Scholar 

  56. Bohlen und Halbach F: Cornflakes, die das Altern verzogern (Interview mit Schellenberger R, Schwagerl C, Berliner Zeitung, (2000) Nr 199, 26./27.August

    Google Scholar 

  57. Brzezinski A: Melatonin in humans. New Engl J Med (1997) 336:186–195

    Article  PubMed  CAS  Google Scholar 

  58. Davidson JM, Chen H, Crapo L, Gray GD, Greenleaf WJ, Catania JA: Hormonal changes and sexual function in aging men. J Clin Endocrinol Metab (1983) 57:71–77

    Article  PubMed  CAS  Google Scholar 

  59. Derouet H, Eckert R, Stamm B, Georg T, Ullrich V, Isenberg E, Wehberg C, Riepen T, Ziegler M: Pathogenetische und klinische Gesichtspunkte niedriger Ostradiolspiegel beim Mann. Urologe A (2000) 39:228–234

    Article  PubMed  CAS  Google Scholar 

  60. Habenicht UF: Estrogens for men: good or bad news. The Aging Male (1998) 1:73–79

    Article  Google Scholar 

  61. Hermann M, Berger P: Hormone supplementation for the aging male? Exp Gerontol (1999) 34:923–933

    Article  PubMed  CAS  Google Scholar 

  62. Longcope C: The metabolism of dehydroepiandrosterone sulfate and dehydroepiandrosterone. The Aging Male (1998) 1:51–55

    Article  Google Scholar 

  63. Maugeri D, Panebianco P, Barbagallo P, Malaguarnera M, Curasi MP, Russo MS, Santangelo A, Speciale S, Scarpinato RA: Estrogens and euostrogenesis in men. Eur Rev Med Pharmakol Sci (1998) 2:189–192

    CAS  Google Scholar 

  64. Maisey DS, Vale ELE, Cornelissen PL, Tovee MJ: Characteristics of male attriveness for women. Lancet (1999) 353:1500

    Article  PubMed  CAS  Google Scholar 

  65. Oettel M: Vortrag Symposium Hormonelle Substitution beim alternden Mann, Berlin 20.5.2000, Urologe B (Beilage Heft 4) (2000) 40

    Google Scholar 

  66. Ofcese J: Cellular and molecular mechanisms mediating melatonin action: a review. The Aging Male (1998) 1:113–128

    Article  Google Scholar 

  67. Pollak J: Ostrogentherapie beim alternden Mann aus kardiologischer Sicht in: Plas E, Riedl CR, Pflüger H (Hrsg.) Andropause, Thieme, Stuttgart (2000) 74–78

    Google Scholar 

  68. Vermeulen A: Hormonal substitution in elderly males: sense or nonsense? The Aging Male (2000) 3 (Suppl. 1):2

    Google Scholar 

Download references

Authors
  1. S. Lenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Fahlenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2001 D. Fahlenkamp, K. J. G. Schmailzl, S. Lenk

About this chapter

Cite this chapter

Lenk, S., Fahlenkamp, D. (2001). Testosteronsubstitution in der Praxis. In: Der alternde Mann. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56524-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56524-3_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62571-8

  • Online ISBN: 978-3-642-56524-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation